Improving Investments in Healthcare Industry Beneficial for Drug Device Combination Products Market

Transparency Market
Research
Drug Device Combination Products Market - Global Industry Analysis, Size,
Share, Growth, Trends and Forecast, 2013 – 2019
The Global Drug Device Combination Products Market to Grow at 7.9%
CAGR between 2013 and 2019
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
117 Page ReportPublished Date
24-Dec-2013
Buy Now Request Sample
Press Release

E-Prescribing Market
2
A recent study by Transparency Market Research (TMR) forecasts that the global drug device combination
products market will grow at a CAGR of 7.9% between the years 2013 to 2019. TMR, a market intelligence firm
based in the United States, in its report says that the global drug device combination products market which was
valued at US$66 billion in 2012 will report a market value worth US$115 billion by 2019. The report is titled
‘Drug Device Combination Products Market - Global Industry Analysis, Size, Share, Growth, Trends and
Forecast, 2013 - 2019’.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/drug-device-combination.html
According to the U.S. Food and Drug Administration, drug device combination products are defined as
therapeutic products comprising an active pharmaceutical ingredient and a medical device that are physically
and/or chemically, combined to be produced as a single product. The drug present in the device may be
impregnated or surface coated. Such products can be designed for local as well as systemic administration of drug
to the patient. Recently, combination products are emerging as innovative medical products due to their
contribution in advancing medical care and are thus expected to have major impact in the coming years.
Moreover, these products offer several advantages which include reduced adverse side effects, improved patient
compliance, controlled release administration of drug, and also provide targeted drug delivery. The major product
types in the market include drug eluting stents, infusion pumps, photosensitizers, orthopedic combination
products, wound care combination products, inhalers, transdermal patches and others which include intraocular
implants and drug eluting beads. Various emerging technologies such as implants with drugs to permit faster
healing, relief from pain and decreased morbidity currently form the major driver for the growth of this market.
The global drug device combination products market was valued at USD 66 billion in 2012 and is expected to
grow at a CAGR of 7.9% from 2013 to 2019, to reach an estimated value of USD 115billion in 2019.
Request A Sample Of This Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1534
REPORT DESCRIPTION

3
High incidence rates of chronic pain causing diseases, prostate cancer, diabetic retinopathy, cardiovascular
diseases, colorectal cancer, asthma, obesity along with rapidly aging global population also form the key drivers
for the global drug device combination products market. Government and NGO initiatives to promote drug
delivery implants, rising number of interventional cardiologists and increase in the demand for minimally invasive
surgeries are some of the other factors propelling the growth of the market. Introduction of biodegradable drug
delivery technologies willserve as future growth opportunities for various drug device combination products.
However, product recalls act as a major growth restraint for the market due to incidences such as adverse side
effects to the patient. Also, these products form a challenge to FDA owing to their classification overlapping the
regulated products and thus complicating their approval process.
Geographically, North America dominated the global drug device combination products market and is expected
to continue to lead in terms of revenue generation throughout the forecast period. The market in North American
region was valued at USD 28.5 billion in the year 2012.Asia-Pacific is considered as the most lucrative market
for drug device combination products owing to the increase in incidences of cardiovascular diseases, diabetes
related disorders and obesity through 2019. The leading players in the market for drug device combination
products are Abbott Laboratories, Inc., Medtronic, Inc., Boston Scientific Corporation, CareFusion Corporation,
Allergen, Inc. and others.
Browse Full Press Release @ http://www.transparencymarketresearch.com/pressrelease/drug-device-
combination.htm
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
TABLE OF CONTENT

4
1.3.2 Primary Research
1.3.3 Statistical Models
1.3.4 List of Abbreviations
1.3.5 Assumptions and Stipulations
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Market Definition and Overview
3.2 Market Drivers
3.2.1 Rise in aging population and consequent cases of chronic diseases worldwide
3.2.2 Increasing demand for minimally invasive products
3.3 Market Restraints
3.3.1 Infections from drug device combination products such as implants and associated product recalls
3.4 Market Opportunities
3.4.1 Growth opportunities in emerging economies with high unmet needs
3.4.2 Introduction of biodegradable technology based products
3.5 Porter’s Five Forces Analysis: Global Drug Device Combination Products Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Drug Device Combination Products Market, by Types
Chapter 4 Global Drug Device Combination Products, by Type, Size and Forecast, 2011-2019 (USD Billion)
4.1 Introduction
4.1.1 Global Drug Device Combination Products Market Revenue, 2011 - 2019 (USD Billion)
4.2 Drug Eluting Stents
4.2.1 Global Drug Eluting Stents Market Revenue, 2011 - 2019 (USD Billion)
4.2.2 Coronary Stents
4.2.2.1 Global Coronary Drug Eluting Stents Market, 2011-2019 (USD Billion)

5
4.2.3 Peripheral Vascular Stents
4.2.3.1 Global Peripheral Vascular Drug Eluting Stents Market, 2011-2019 (USD Billion)
4.3 Infusion Pumps
4.3.1 Global Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
4.3.2 Implantable Infusion Pumps
4.3.2.1 Global Implantable Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
4.3.3 Ambulatory Infusion Pumps
4.3.4 Global Ambulatory Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
4.4 Photosensitizers
4.4.1 Global Photosensitizers Market Revenue, 2011-2019 (USD Billion)
4.5 Orthopedic Combination Products
4.5.1 Global Orthopedic Combination Products Market Revenue, 2011-2019 (USD Billion)
4.5.2 Antibiotic Bone Cement
4.5.3 Bone Graft Implants
4.6 Wound Care Combination Products
4.6.1 Antibiotic Wound Care Products
4.6.2 Global Wound Care Combination Products Market Revenue, 2011-2019 (USD Billion)
4.7 Inhalers
4.7.1 Global Inhalers Market Revenue, 2011-2019 (USD Billion)
4.7.2 Nebulizers
4.7.2.1 Global Nebulizers Market Revenue, 2011-2019 (USD Billion)
4.7.3 Metered Dose Inhalers
4.7.3.1 Global Metered Dose Inhalers Market Revenue, 2011-2019 (USD Billion)
4.7.4 Dry Powder Inhalers
4.7.4.1 Global Dry Powder Inhalers Market Revenue, 2011-2019 (USD Billion)
4.8 Transdermal Patches
4.8.1 Global Transdermal Patches Market Revenue, 2011-2019 (USD Billion)
4.9 Other Drug Device Combination Products
4.9.1 Global Other Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
4.9.2 Intraocular Implants

6
4.9.3 Drug Eluting Beads
Chapter 5 Global Drug Device Combination Products, by Geography, 2011 - 2019 (USD Million)
5.1 Overview
5.1.1 Global Drug Device Combination Products Market, by Geography, 2011 - 2019 (USD Billion)
5.1.2 Global Drug Device Combination Products Market, by Geography, 2012 and 2019 (%)
5.2 North America
5.2.1 North America Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)
5.3 Europe
5.3.1 Europe Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)
5.5 Rest of the World
5.5.1 RoW Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)
Chapter 6 Competitive Landscape
6.1 Market Share Analysis: Global Drug Device Combination Products Market
6.1.1 Methodology
6.1.2 Market Share Analysis for the global drug eluting stents market, by key players, 2012
6.1.3 Market share analysis for the global infusion pumps market, by key players, 2012
Chapter 7 Recommendations
7.1 Research and Development Initiatives
7.2 Converging Technologies to Yield Efficiencies
7.3 Mergers and Acquisitions to Improve Market Presence
7.4 Conducting Product Awareness Programs
7.5 Investing in Emerging Economies
Chapter 8 Company Profiles
8.1 Abbott Laboratories

7
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Allergan, Inc.
8.3 Alcon, Inc.
8.3.5 Recent Development
8.4 Arrow International, Inc.
8.5 Bausch & Lomb, Inc.
8.6 Boston Scientific Corporation

8
8.6.4.1 Acquisitions
8.7 CareFusion Corporation
8.8 Covidien PLC
8.9 C.R. Bard, Inc.
8.10 Ethicon, Inc.

9
8.11 Medline Industries, Inc.
8.12 Medtronic, Inc.
8.13 Mylan, Inc.
8.14 Pinnacle Biologics, Inc.
8.15 Stryker Corporation
8.16 Terumo Corporation

10
8.17 W. L. Gore & Associates, Inc.
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and
consulting services. TMR’s global and regional market intelligence coverage includes industries such as
pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among
others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts,
competitive landscape, detailed segmentation, key trends, and strategic recommendations.
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
About Us
Contact

Improving Investments in Healthcare Industry Beneficial for Drug Device Combination Products Market

Recomendados

Recomendados

Mais conteúdo relacionado

Último

Último (20)

Destaque

Destaque (20)

Improving Investments in Healthcare Industry Beneficial for Drug Device Combination Products Market